Subscribe To
Processa pharmaceuticals to present pcs12852 gastroparesis results at the digestive disease week 2023 annual meeting
HANOVER, MD, April 28, 2023 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage ...
April 28, 2023, 8:15 am
Hillstream biopharma announces pricing of public offering
BRIDGEWATER, N.J., April 27, 2023 (GLOBE NEWSWIRE) — Hillstream BioPharma, Inc. (Nasdaq: HILS) (“Hillstream” or the “Company”), a biotechnol...
April 28, 2023, 1:50 am
Miromatrix to report first quarter 2023 financial results
EDEN PRAIRIE, Minn., April 27, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (NASDAQ: MIRO), a life sciences company pioneering a ...
April 27, 2023, 10:00 pm
Oncternal therapeutics to provide business update and report first quarter 2023 financial results
SAN DIEGO, April 27, 2023 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the ...
April 27, 2023, 9:00 pm
Tavros therapeutics and openbench expand strategic collaboration for small molecule drug discovery
Multi-target collaboration leverages Tavros’ proprietary functional genomic discovery program and OpenBench’s screening platform Partnership strea...
April 27, 2023, 12:19 pm
Hcw biologics secures $26.25 million non-dilutive financing with asset-backed development loan
Provides funding for buildout of new headquarters and manufacturing facility Capital requirements now funded into 2025 MIRAMAR, Fla., April 27, 2023 (...
April 27, 2023, 11:40 am
Traction uranium on path to discovery with exposure to uranium bearing fluids at hearty bay
Traction Uranium Corp provided a promising update on the completed Hearty Bay research program focused on the core samples derived from the winter 202...
April 26, 2023, 4:37 pm
Arbutus biopharma clinical hold slows hepatitis b momentum: broker
Analysts at Baird Equity Research have awarded Arbutus Biopharma a ‘Neutral' rating after the early-stage biopharmaceutical company announced that ...
April 26, 2023, 2:44 pm
Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) — Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...
April 26, 2023, 2:08 pm
Galera to present one-year reductions in cisplatin-related chronic kidney disease data from roman trial at 2023 american society of clinical oncology (asco) annual meeting
MALVERN, Pa., April 26, 2023 (GLOBE NEWSWIRE) — Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on deve...
April 26, 2023, 2:00 pm
Cullinan oncology to present first clinical data evaluating novel anti-mica/b antibody, cln-619, in patients with advanced solid tumors at asco 2023
CAMBRIDGE, Mass., April 26, 2023 (GLOBE NEWSWIRE) -- Cullinan Oncology, Inc. (Nasdaq: CGEM), a biopharmaceutical company focused on modality-agnostic...
April 26, 2023, 10:08 am
Mindset pharma files two international patent applications under the patent cooperation treaty
Mindset Pharma Inc (CSE:MSET, OTCQB:MSSTF) said it has filed two international patent applications under the Patent Cooperation Treaty (PCT) to prote...
April 26, 2023, 8:20 am
X4 pharmaceuticals to report first-quarter 2023 financial results and host a conference call and webcast on may 4, 2023
BOSTON, April 26, 2023 (GLOBE NEWSWIRE) -- X4 Pharmaceuticals, Inc. (Nasdaq: XFOR), a leader in the discovery and development of ...
April 26, 2023, 8:01 am
Collagen peptide & gelatin market to cross usd 7.8 bn revenue, globally by 2031, says transparency market research
Global collagen peptide and gelatin market growth is driven by the increase in demand for nutraceuticals and research & development studies pertaining...
April 25, 2023, 9:30 pm
Tracon pharmaceuticals announces arbitration award in dispute with i-mab
SAN DIEGO, April 25, 2023 (GLOBE NEWSWIRE) — TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a cos...
April 25, 2023, 11:41 am
Sirona biochem stock climbs on anti-aging compound clinical trial results
Sirona Biochem (TSX-V:SBM) Corp shares surged 77% to $0.15 on Tuesday after the cosmetic ingredient and drug discovery company announced that clinic...
April 25, 2023, 11:40 am
Virios therapeutics up 75% on fibromyalgia phase 3 proposal
Virios Therapeutics Inc. (NASDAQ: VIRI) is a developmental-stage biotechnology company specializing in novel <...
April 25, 2023, 11:30 am
Arbutus announces fda clinical hold on ind application for ab-101, an oral pd-l1 inhibitor
WARMINSTER, Pa., April 25, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-sta...
April 25, 2023, 11:30 am
Virios therapeutics stock doubles as fibromyalgia program moves forward
Virios Therapeutics shares more than doubled after the biotechnology company announced that its proposed Phase 3 program featuring its lead developmen...
April 25, 2023, 10:48 am
Iovance biotherapeutics to present at upcoming conferences
SAN CARLOS, Calif., April 24, 2023 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a late-stage biotechnology company developing
April 24, 2023, 7:01 am